Try GOLD - Free

BioSpectrum Asia Magazine - BioSpectrum Asia Feb 2025

Go Unlimited with Magzter GOLD

Read BioSpectrum Asia along with 9,500+ other magazines & newspapers with just one subscription

View Catalog

1 Month

$14.99

1 Year $149.99

$149.99

$12/month

(OR)

Subscribe only to BioSpectrum Asia

Gift BioSpectrum Asia

Cancel Anytime.

(No Commitments) ⓘ

If you are not happy with the subscription, you can email us at help@magzter.com within 7 days of subscription start date for a full refund. No questions asked - Promise! (Note: Not applicable for single issue purchases)

Digital Subscription

Instant Access ⓘ

Subscribe now to instantly start reading on the Magzter website, iOS, Android, and Amazon apps.

Verified Secure

payment ⓘ

Magzter is a verified Stripe merchant.

In this issue

APAC takes Centre stage in AI-Driven Drug Discovery The Asia-Pacific (APAC) region is rapidly emerging as a leader in AI-driven drug discovery, fuelled by robust research ecosystems and strong industry collaboration. Substantial investments, cutting-edge technologies, and strategic partnerships are optimising drug development efficiency. As Artificial Intelligence (AI) has become more embedded into many facets of everyday life, it has become an indispensable part of the drug discovery landscape. 2024 was the year of reckoning when AI in drug discovery received the highest validation—three researchers who leveraged the neural network AI programme AlphaFold to predict protein structures won the Nobel Prize in Chemistry. The industry is pushing ahead, using tech to make the business of drug development faster, safer, and more economical. Morgan Stanley estimates that AI's use in drug development could lead to 50 more successful treatments over a decade, potentially creating a $50 billion market.

Singapore launches Global Heat Health Information Network Southeast Asia Hub

The Heat Resilience & Performance Centre (HRPC) at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has been officially designated as the Global Heat Health Information Network (GHHIN) Southeast Asia (SEA) Hub, a recognition that underscores its leading role in advancing heat resilience.

1 mins

China approves GSK's Nucala for treatment of adults with chronic rhinosinusitis

China National Medical Products Administration (NMPA) has approved GSK's Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with chronic rhinosinusitis with nasal polyps (CRSWNP) for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control.

1 mins

Japan gives nod to first subcutaneous immunoglobulin (fSCIG) therapy

Japanese Ministry of Health, Labour and Welfare has approved the use of Takeda's HYQVIA [Immune Globulin Infusion 10 percent (Human) with Recombinant Human Hyaluronidase] in patients with agammaglobulinemia or hypogammaglobulinemia, disorders characterized by very low or absent levels of antibodies and an increased risk of serious recurring infection caused by primary immunodeficiency (PID) or secondary immunodeficiency (SID).

1 mins

UAE nears completion of National Health Survey

The Ministry of Health and Prevention (MOHAP) in the United Arab Emirates (UAE) has announced a significant milestone in its national surveys project, with 95 percent completion rate for the National Health Survey and 78 percent for the National Nutrition Survey, marking a significant step toward building a robust health database.

1 mins

Merck strikes partnership worth $1.9 B with Chinese biotech Hansoh

Merck, known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist.

1 mins

Innovent Biologics enters into billion-dollar oncology deal with Roche

China-based Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, has announced a collaboration and exclusive license agreement with Swiss pharma firm Roche to advance the development of IBI3009, a novel DLL3-targeted antibody drug conjugate (ADC) candidate.

1 mins

Neuberg Diagnostics secures Rs 940 Cr from Kotak Alt

Neuberg Diagnostics has secured Rs 940 crore from Kotak Alt in the largest-ever primary fund-raise in the Indian diagnostics sector.

1 mins

Abu Dhabi announces AED 19 M in grants through Healthcare Research and Innovation Fund

The Department of Health - Abu Dhabi (DOH), the regulator of the healthcare sector in the Emirate, in partnership with the Authority of Social Contribution - Ma'an, the Abu Dhabi Government's dedicated platform that connects the government, private sector, and wider community to address key social priorities, has awarded over AED 19 million in grants through the Healthcare Research and Innovation Fund.

1 mins

Fujirebio and Eisai to establish diagnostic technologies for neurodegenerative diseases

Fujirebio Holdings, a wholly-owned subsidiary of H.U. Group Holdings, Inc., and Eisai Co., in Japan, have entered into a Memorandum of Understanding (MoU) for the joint research and social implementation of novel blood-based biomarkers in the field of neurodegenerative diseases.

1 mins

Lonza expands capsule manufacturing capacity in India and China

Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has announced capacity expansions at its sites in Rewari (India) and Suzhou (China).

1 mins

Bio-Thera Solutions & Tabuk Pharma to commercialise Stelara biosimilar in Saudi Arabia

China-based Bio-Thera Solutions Inc.,

1 mins

AbbVie Biopharma strengthens digital strategies for clinical trials in Taiwan

National Taiwan University Hospital (NTUH) and AbbVie Biopharmaceuticals GmbH Taiwan Branch (AbbVie) have signed a cooperation agreement, with the agreement jointly signed by President Ming-Shiang Wu of NTUH and General Manager Richard Sun of AbbVie.

1 mins

Primo Biotech partners with SHINE Technologies to advance precision cancer care in APAC

Taiwan-based startup Primo Biotechnology has announced a strategic partnership with US-based SHINE Technologies, LLC, a global leader in nuclear medicine production.

1 mins

Alebund Pharmaceuticals announces first closing of RMB 550 M in Series C financing

Shanghai-based Alebund Pharmaceuticals, an integrated biopharmaceutical company focusing on developing innovative therapies for renal diseases and related chronic conditions, has announced the closing of RMB 550 million in Series C financing.

1 mins

RNT Health Insights receives 2nd US FDA BDD for oesophageal cancer detection tool

RNT Health Insights, an Indian health-tech startup specialising in AI-assisted diagnostic solutions for the accurate detection of pathologies during endoscopic procedures, has been granted its second US FDA Breakthrough Device Designation (BDD) for its Oesophageal Cancer detection tool.

1 mins

PAHO launches interactive dashboard to monitor avian influenza in the Americas

The Pan American Health Organization (PAHO) has launched an interactive dashboard to monitor avian influenza A(H5N1) cases in the Americas.

1 mins

Gavi facilitates donations of mpox vaccine doses, with first delivery to Nigeria

A shipment of 11,200 doses, donated by the United States of America and facilitated by Gavi, the Vaccine Alliance, were recently shipped to Abuja, Nigeria.

1 mins

US FDA issues draft guidance for developers of AI-enabled medical devices

The US Food and Drug Administration (FDA) has issued draft guidance that includes recommendations to support development and marketing of safe and effective artificial intelligence (AI)enabled devices throughout the device's Total Product Life Cycle.

1 mins

UK declares biggest investment of £126 M into hospices

The biggest investment in a generation for hospices has been announced by the UK government, ensuring that hospices can continue to deliver the highest quality end-of-life care possible for their patients, families, and loved ones.

1 mins

APAC takes Centre stage in Al-Driven Drug Discovery

The Asia-Pacific (APAC) region is rapidly emerging as a leader in Al-driven drug discovery, fuelled by robust research ecosystems and strong industry collaboration.

10+ mins

"China and Asia are already the global leaders of Antibody-drug conjugates"

Chime Biologics, based in Asia, has positioned itself as a global leader in the Contract Development and Manufacturing Organisation (CDMO) sector.

4 mins

"There is a need for pharmaceutical companies to build HCP relationships, backed by scientific credibility"

Docquity, headquartered in Singapore, is Southeast Asia's largest professional network for verified healthcare professionals (HCPs), connecting over 410,000 doctors across the region.

4 mins

"There remains a high unmet need for new & alternative treatment options for prurigo nodularis & atopic dermatitis"

Asia-Pacific region houses some of Galderma's fastest growing markets, where sales have fueled a strong performance.

5 mins

"Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly"

2024 saw Japanese medtech firm Olympus receiving approval for the company's first cloud-based AI endoscopy devices in the US and Europe, marking a significant milestone in Olympus' efforts to enhance clinical outcomes and operational efficiency in endoscopy, paving the way to launch its upcoming endoscopy solution, the “Intelligent Endoscopy Ecosystem”.

5 mins

Middle East: A rising powerhouse in Medtech and Diagnostics.

The Middle East's medtech and diagnostics sector is undergoing a dynamic transformation, fuelled by rapid technological advancements and strategic healthcare investments.

5 mins

When Clinical Trials Suffer From 'Complicated' Interactions

Diversity in culture, language, and data gathering methods will further increase the difficulty of clinical trials as they become more international, particularly with the growing number of sites being employed across China, Japan, South Korea, and India.

5 mins

IIT-B joins hands with Tohoku University to offer MTech, PhD dual degree programmes

The Indian Institute of Technology, Bombay (IIT-B) has entered into a Memorandum of Understanding (MoU) with Japan's Tohoku University to launch the IIT Bombay-Tohoku University Joint Academic & Research Programme.

1 mins

Universities in China & Pakistan ink MoU for advanced research in health sciences

The School of Medicine, Shihezi University, Xinjiang, China, and the Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan, have signed a landmark Memorandum of Understanding (MoU) to foster collaboration in cutting-edge scientific research and academic exchange.

1 mins

Singapore appoints Tan Chong Meng as Chairman of National University Health System

The Minister for Health has appointed Tan Chong Meng as the Chairman of the Board of the National University Health System (NUHS) from January 1, 2025 to December 31, 2027.

1 mins

Dr Krishna M Ella receives prestigious INSA India fellowship

Dr Krishna Ella, a distinguished scientist, co-founder and Executive Chairman of Bharat Biotech International, has been recognised with the prestigious India Fellowship of the Indian National Science Academy (INSA) for the year 2025, for his contributions to new knowledge, discoveries, development of new vaccine technologies, noteworthy improvement in existing technologies.

1 mins

BeiGene names Giancarlo Benelli as Head of Europe biz

BeiGene, a Hong Kong-headquartered oncology company that intends to change its name to BeOne Medicines Ltd., has announced the appointment of Giancarlo Benelli as Senior Vice President and Head of Europe, effective January 1.

1 mins

Julia Wang steps in as Executive Vice President and CFO at Labcorp

Labcorp, a global leader of innovative and comprehensive laboratory services, has announced that Executive Vice President and Chief Financial Officer (CFO) Glenn Eisenberg has retired from the company and Julia Wang has joined this position.

1 mins

Prof. Christian Wolfrum to join NTU as Deputy President and Provost

Nanyang Technological University, Singapore (NTU Singapore) has announced that Professor Christian Wolfrum, an eminent biomedical scientist, will be joining the University as the next Deputy President and Provost.

1 mins

Singapore boosts chemotherapy uptake in breast cancer treatment with localised magnetic fields

Researchers at the National University of Singapore (NUS) have developed a non-invasive method to improve the effectiveness of chemotherapy while reducing its harmful side effects.

1 mins

Korea develops innovative injectable adhesive hydrogel for bone regeneration

A research team from South Korea-based Pohang University of Science and Technology or POSTECH's Department of Chemical Engineering and Graduate School of Convergence Science and Technology, along with the Department of Chemical Engineering, has developed an innovative injectable adhesive hydrogel for bone regeneration.

1 mins

Japan suggests addition of PVA into drugs for strong antitumour activity

Treatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addition of polyvinyl alcohol (PVA), the same ingredient used in children's glue.

1 mins

Australia manufactures 3D printed scaffolding to rebuild jaw bones

Clinicians have successfully used custom-made 3D printed bone scaffolds, printed on-site at The University of Queensland (UQ) in Australia, to rebuild part of a man's jawbone.

1 mins

Bruker launches infrared imaging microscope for pharma and life science research

US-based Bruker Corporation has announced the launch of the LUMOS II ILIM, a quantum cascade laser (QCL) based infrared (IR) imaging microscope.

1 mins

Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities

Qiagen has announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more than two-fold increase in the number of targets that can be simultaneously analysed from a single biological sample.

1 mins

Bio-Techne and Waters ink comarketing agreement for biotherapeutic characterisation

American life sciences company Bio-Techne Corporation, a leader in automated platforms for biotherapeutic characterization, has announced a co-marketing and co-promotion agreement with Waters Corporation aimed at expanding the reach of advanced biotherapeutic characterization and development processes.

1 mins

Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers

US-based Repligen Corporation has announced the commercial launch of its CTech SoloVPE PLUS System, the most advanced UV-based Variable Pathlength Technology system now available to biopharmaceutical manufacturers.

1 mins

Read all Stories from BioSpectrum Asia

BioSpectrum Asia Magazine Description:

Publisher: MM-Activ-Sci-Tech-Communication

Category: Business

Language: English

Frequency: Monthly

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.

* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.

* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.

* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.

* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.